Conditions: Rosacea
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1421
Healthy volunteers: no

Brief summary:
The objective of this study is to assess the effectiveness, safety, subject satisfaction and quality of life with Oracea® when used as monotherapy or as add-on therapy to existing topical regimens for the treatment of rosacea.

Detailed description:

Arms:
arm 1: Oracea as monotherapy arm 2: Oracea® as add-on Therapy (Oracea® + Metronidazoles and/or Azelaic Acids and/or Sodium Sulfacetamides

Interventions: intervention 1: doxycycline (Oracea®) 40 mg modified release as monotherapy intervention 2: doxycycline (Oracea®) 40 mg modified release as add-on therapy
Intervention descriptions: intervention 1: Take once daily in the morning intervention 2: Take once daily in the morning

Protocol document: